Bacillus Calmette Guerin: Clinical Trials

5 trials of Bacillus Calmette Guerin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 active not recruiting. 2 Phase 3, 2 Phase 4, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Active not recruiting 1, Completed 1
Phase 42Active not recruiting 1, Completed 1
Phase 21Completed 1

Follow Bacillus Calmette Guerin: new trials by email Literature Review of Bacillus Calmette Guerin trials Research Report on Bacillus Calmette Guerin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Intravesical B.C.G and Gemcitabine on Semen Analysis and Testicular Volume in NMIBC
Bacillus Calmette Guerin, Gemcitabine HCL (Gemzar) - Urothelial Carcinoma Bladder, Sperm Count, Low
Phase 4CompletedAssiut University862023-04-012026-10-29
Intravesical BCG vs GEMDOCE in NMIBC
Gemcitabine, Docetaxel, Bacillus Calmette Guerin - Non-muscle-invasive Bladder Cancer
Phase 3Active not recruitingECOG-ACRIN Cancer Research Group8702023-02-072026-09-15
Immunological Response of Bladder Cancer Patients Under BCG
Bacillus Calmette Guerin, PLACEBO - Bladder Cancer, Bacillus Calmette-Guerin
Phase 3CompletedUniversity of Campinas, Brazil302021-09-032024-12-09
NORTH-REG Dwell-Time Study
Bacillus Calmette Guerin - Side Effect of Drug
Phase 4Active not recruitingJørgen Bjerggaard Jensen3142021-02-032026-03-03
Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder
Mycobacterium w, BCG (Bacillus Calmette-Guerin) - Bladder Cancer
Phase 2CompletedCadila Pharnmaceuticals1222008-08-282021-08-17

Conditions studied

Non-Muscle Invasive Bladder Neoplasms (2)  ·  Urinary Bladder Neoplasms (2)  ·  Fibrosis (1)  ·  Oligospermia (1)

Sponsors

Assiut University (1)  ·  Cadila Pharnmaceuticals (1)  ·  ECOG-ACRIN Cancer Research Group (1)  ·  Jørgen Bjerggaard Jensen (1)  ·  University of Campinas, Brazil (1)

Countries

Brazil (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Iceland (1)  ·  India (1)  ·  Sweden (1)  ·  United States (1)

Top investigators

Ahmed M Eltaher, professor (1)  ·  Amillal Bhat, MD (1)  ·  Anup Kundu, MD (1)  ·  B. R. Srivastav, MD (1)  ·  H. K. Moorthy, MD (1)  ·  Hosny A Behnsawy, associate professor (1)  ·  Jitendra Amlani, MD (1)  ·  Kim Mammen, MD (1)  ·  Leonardo O Reis, MD, PhD (1)  ·  Mahesh Desai, MD (1)  ·  Mohammed H Zarzour, lecturer (1)  ·  N K Mohanty, MD (1)  ·  Padmaraj Hegde, MD (1)  ·  Purshottam K. Puri, MD (1)  ·  Rajeev Sood, MD (1)

Results publications

PMID 37400353, PMID 40375148, PMID 41436847, PMID 42605566

NIH funding

U10CA180820 (1)